https://www.businesswire.com/news/home/20260529645249/en/ASCO-2026-Bayer-Shares-New-Findings-for-NUBEQA-darolutamide-Regarding-Cognitive-Decline-in-Men-with-Advanced-Prostate-Cancer-Compared-to-Enzalutamide-in-Phase-II-ARACOG-Head-to-Head-Trial 2026-05-30T21:24:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530804788/es 2026-05-30T19:51:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530248381/fr 2026-05-30T19:51:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530963084/it 2026-05-30T19:51:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530204190/nl 2026-05-30T19:51:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530902647/en/Salubris-Biotherapeutics-Announces-Updated-Phase-12-Data-for-JK06-a-5T4-Targeted-Antibody-Drug-Conjugate-at-the-2026-American-Society-of-Clinical-Oncology-Annual-Meeting 2026-05-30T18:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530067460/en/BW-LPG-Enters-Into-Agreement-for-Eight-90cbm-Panamax-Newbuildings-with-Hyundai-Heavy-Industries 2026-05-30T16:03:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530475386/en/Mirum-Pharmaceuticals-Announces-New-Data-from-Rare-Liver-Disease-Programs-Presented-at-the-EASL-International-Liver-Congress-2026 2026-05-30T16:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530374928/en/INVESTOR-NOTICE-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-Sportradar-Group-AG-SRAD-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit 2026-05-30T15:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530141381/en/CVLT-INVESTOR-DEADLINE-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-Commvault-Systems-Inc.-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit 2026-05-30T15:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530932788/en/Massive-Bio-Announces-Next-Generation-Reticulum-Nexus-Product-Suite-at-ASCO-2026 2026-05-30T14:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260529816966/en/Exelixis-Announces-Results-from-Subgroup-Analysis-of-Phase-3-CABINET-Pivotal-Trial-Evaluating-CABOMETYX-cabozantinib-in-Non-Functional-and-Functional-Neuroendocrine-Tumors-at-ASCO-2026 2026-05-30T14:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530865068/fr 2026-05-30T13:31:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530490588/en/Global-Real-Assets-Trust-Reports-Q1-2026-Results 2026-05-30T13:31:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530598089/en/Tempus-Launches-the-PRECISION-Challenge-a-National-Program-Opening-Its-Foundation-Model-Work-to-the-Broader-Research-Community 2026-05-30T12:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530351488/en/TALZENNA-Plus-XTANDI-Improves-Radiographic-Progression-Free-Survival-by-More-Than-50-in-Metastatic-Prostate-Cancer 2026-05-30T12:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530183615/en/ENZAMET-Trial-Shows-Veracytes-Decipher-Prostate-Test-Identifies-Which-Patients-Benefit-from-Adding-Chemotherapy-in-Metastatic-Prostate-Cancer 2026-05-30T12:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530052195/en/Tune-Therapeutics-Presents-Positive-Phase-1b2a-Proof-of-Concept-Data-on-TUNE-401-a-First-in-Class-Epigenetic-Silencer-for-Patients-with-Hepatitis-B-at-EASL-2026 2026-05-30T12:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530890115/en/Immunome-Announces-Detailed-Phase-3-RINGSIDE-Data-for-Varegacestat-in-Adults-with-Progressing-Desmoid-Tumors-at-the-2026-ASCO-Annual-Meeting 2026-05-30T12:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530829355/en/Tempus-Introduces-Preview-Bridging-the-Critical-Time-Gap-Between-Diagnostic-Order-and-Definitive-Results 2026-05-30T12:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530544179/en/Encouraging-Global-Phase-II-Ivonescimab-Data-in-First-Line-Metastatic-Colorectal-Cancer-Presented-at-ASCO-2026 2026-05-30T12:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260530259024/en/Incytes-Pivotal-frontMIND-Trial-Showed-Tafasitamab-MonjuviMinjuvi-Combination-Significantly-Prolonged-Progression-free-Survival-Reducing-the-Risk-of-Disease-Progression-or-Death-by-25-in-Patients-with-Previously-Untreated-High-risk-DLBCL 2026-05-30T12:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260529745319/en/FCPT-Announces-Agreement-to-Acquire-up-to-102-Mission-Pet-Health-Veterinary-Properties-for-%24268-Million 2026-05-30T02:20:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260529103245/en/AVAV-INVESTOR-NOTICE-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-AeroVironment-Inc.-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit 2026-05-30T02:05:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260528413644/es 2026-05-30T01:42:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260529472902/en/Shareholder-Notice-Robbins-LLP-Informs-Investors-of-the-Lucid-Group-Inc.-Class-Action 2026-05-30T00:39:00.000Z weekly 0.5